Table 1.
Clinical/pathological Characteristics | Triple Negative BC(n = 849) | |
---|---|---|
Number | Proportion% | |
Age Median (range) | 53(23–87) | |
≤50 ys | 370 | 43.6 |
>50 ys | 479 | 56.4 |
Menopausal status | ||
premenopausal | 398 | 46.9 |
postmenopausal | 451 | 53.1 |
Tumor size | ||
T1 | 380 | 44.8 |
T2 | 438 | 51.6 |
T3 | 17 | 2 |
Unknown | 14 | 1.6 |
Grade | ||
I-II | 363 | 42.8 |
III | 464 | 54.6 |
Unknown | 22 | 2.6 |
Nodal status | ||
Negative | 551 | 64.9 |
Positive LVI1 | 298 | 35.1 |
Negative | 663 | 78.1 |
Positive | 186 | 21.9 |
Chemotherapy | ||
Yes | 795 | 93.6 |
No | 38 | 4.5 |
Unknown | 16 | 1.9 |
Surgery | ||
BCS2 + RT3 | 145 | 17.1 |
Radical Mastectomy | 627 | 73.9 |
Mastectomy | 40 | 4.7 |
Other | 37 | 4.3 |
1LVI: lymphvascular invasion.
2BCS: breast conserving surgery.
3RT: radiotherapy.